Sign up to save your podcasts
Or
Share Biosimilars, Brain Myths, Orphan Drugs, and Ebola
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biosimilars, Brain Myths, Orphan Drugs, and Ebola
Hank Greely, Patti Zettler, Dmitry Karshtedt, and Stephanie Bair discuss new developments related to the Biosimilars Act and FDA's orphan drug program, the policy implications of brain myths, and the current Ebola crisis.
View all episodes
By Stanford Law School, Center for Law and the Biosciences
4
11 ratings
Hank Greely, Patti Zettler, Dmitry Karshtedt, and Stephanie Bair discuss new developments related to the Biosimilars Act and FDA's orphan drug program, the policy implications of brain myths, and the current Ebola crisis.